+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Rheumatology Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatology Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
From
Monoclonal Antibodies Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Monoclonal Antibodies Market - Forecasts from 2022 to 2027

  • Report
  • December 2022
  • 142 Pages
  • Global
From
Peanut Allergy Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Peanut Allergy Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator